Investors

banner

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Semler Reports Second Quarter and First Half 2020 Financial Results
2020 Q2 HIGHLIGHTS compared to the corresponding period of 2019:   -- Revenues were $6,373,000, a decrease of 20%   -- Pre-tax net income was $990,000, a decrease of $1,706,000   -- Net income was $0.16 per basic share and $0.13 per diluted share, compared to $0.41 per basic share and $0.32 per
View HTML
Toggle Summary Semler to Report Second Quarter and First Half 2020 Financial Results and Host Conference Call on August 3, 2020
SAN JOSE, Calif. , July 27, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and first
View HTML
Toggle Summary Semler Reports First Quarter 2020 Financial Results
2020 Q1 HIGHLIGHTS compared to the corresponding period of 2019: - Revenues were $9,430,000, which is an increase of 39% - Pre-tax net income of $3,450,000, an increase of $1,596,000, or 86%, compared to $1,854,000 - Net income grew to $0.41 per basic share and $0.33 per diluted share, compared to
View HTML
Toggle Summary Semler to Report First Quarter 2020 Financial Results and Host Conference Call on May 4, 2020
SAN JOSE, Calif. , April 21, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March
View HTML
Toggle Summary Semler Reports Record Fourth Quarter and Year End 2019 Financial Results
2019 HIGHLIGHTS compared to 2018: - Annual revenues increased by 52% - Pre-tax income of $10,701,000, an increase of $5,661,000, or 112%, compared to $5,040,000 - Net income after tax grew to $2.34 per basic share and $1.88 per diluted share, compared to $0.82 per basic share and $0.66 per diluted
View HTML
Toggle Summary Semler to Report Fourth Quarter and Year End 2019 Financial Results and Host Conference Call on March 3, 2020
SAN JOSE, Calif. , Feb. 21, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the fourth quarter and full
View HTML
Toggle Summary Semler Reports Record Third Quarter and Year-to-Date 2019 Financial Results
2019 Q3 HIGHLIGHTS compared to the corresponding period of 2018: - Revenues were $8,902,000, an increase of 60% - Pre-tax income of $3,108,000, an increase of $1,640,000, or 112%, compared to $1,468,000 - Net income grew to $1.20 per basic share and $0.96 per diluted share, compared to $0.24 per
View HTML
Toggle Summary Semler to Report Third Quarter and First Nine Months of 2019 Financial Results and Host Conference Call on October 30, 2019
SAN JOSE, Calif. , Oct. 23, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the third
View HTML
Toggle Summary Semler Reports Record Second Quarter and First Half 2019 Financial Results
2019 Q2 HIGHLIGHTS compared to the corresponding period of 2018: - Revenues were $7,953,000, an increase of 45% - Net income grew to $0.41 per basic share and $0.32 per diluted share, compared to $0.24 per basic share and $0.19 per diluted share - Cash at June 30, 2019 increased to $4,182,000 from
View HTML
Toggle Summary Semler to Report Second Quarter and First Half 2019 Financial Results on July 26, 2019
SAN JOSE, Calif. , July 16, 2019 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second
View HTML

Contact Us

Semler Scientific, Inc.
911 Bern Court
San Jose, CA 95112
877-774-4211